Karpus Investment Management
BIOS

Karpus Investment Management’s BioPlus Acquisition Corp. Class A Ordinary Shares BIOS Stock Holding History

Karpus Investment Management’s Portfolio BIOS Stock Details BIOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-10,235
Closed -$111K – 298
2023
Q3 		$111K Hold
10,235
– – ﹤0.01% 272
2023
Q2 		$109K Hold
10,235
– – ﹤0.01% 314
2023
Q1 		$107K Sell
10,235
-3,025
-23% -$31.3K ﹤0.01% 373
2022
Q4 		$136K Sell
13,260
-20,875
-61% -$212K ﹤0.01% 428
2022
Q3 		$342K Buy
+34,135
New +$341K 0.01% 432

Karpus Investment Management's BIOS Position: Q4 2023 in Review

Karpus Investment Management sold out of BioPlus Acquisition Corp. Class A Ordinary Shares (BIOS) in Q4 2023, closing a stake of 10,235 shares — an estimated $111K sold.

Karpus Investment Management first reported a position in BIOS in Q3 2022 and held it in 5 quarters. The position peaked at $342K in Q3 2022. 0 funds tracked by Wall St. Rank hold BIOS as of Q4 2023.

  • Karpus Investment Management reported no remaining BioPlus Acquisition Corp. Class A Ordinary Shares position as of Q4 2023 after selling out during the quarter.
  • Karpus Investment Management sold 10,235 BioPlus Acquisition Corp. Class A Ordinary Shares shares in Q4 2023, an estimated $111K.
  • Karpus Investment Management first reported a position in BioPlus Acquisition Corp. Class A Ordinary Shares in Q3 2022 and held it in 5 quarters.
  • Karpus Investment Management's BioPlus Acquisition Corp. Class A Ordinary Shares position peaked at $342K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held BioPlus Acquisition Corp. Class A Ordinary Shares as of Q4 2023.

Based on Karpus Investment Management's 13F filing for Q4 2023, filed 13 Feb 2024.